Early Identification of SEPsis SIGNs in Emergency Department

NCT04261621 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 815

Last updated 2023-06-01

No results posted yet for this study

Summary

Objective of SepSIGN project is to validate biomarkers able to predict the clinical worsening of patients freshly admitted at Emergency Department. Targeted population is adult patients, freshly admitted at ED, with a suspected or confirmed infection.

Conditions

Sponsors & Collaborators

  • Vanderbilt University Medical Center

    collaborator OTHER
  • Centre d'Investigation Clinique - Limoges

    collaborator UNKNOWN
  • BioMérieux

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-06
Primary Completion
2022-05-02
Completion
2022-05-02

Countries

  • United States
  • France
  • Monaco

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04261621 on ClinicalTrials.gov